Likewise, several investigators have reported that over 40% of freshly isolated GBM specimens did not contained CD133+ cells, suggesting that CD133 is not an enrichment marker for CSCs in all GBM cases [72-76]. This evidence concerns the gene PROM1 and glioblastoma.